UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039176
Receipt number R000044515
Scientific Title A prospective validation study of diagnostic yield of EUS-FNB estimated by stereomicroscopic visible white core length
Date of disclosure of the study information 2020/02/01
Last modified on 2021/12/22 14:27:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective validation study of diagnostic yield of EUS-FNB estimated by stereomicroscopic visible white core length

Acronym

A prospective validation study of diagnostic yield of EUS-FNB estimated by stereomicroscopic visible white core length

Scientific Title

A prospective validation study of diagnostic yield of EUS-FNB estimated by stereomicroscopic visible white core length

Scientific Title:Acronym

A prospective validation study of diagnostic yield of EUS-FNB estimated by stereomicroscopic visible white core length

Region

Japan


Condition

Condition

Pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of cut-off value of stereomicroscopic visible white core length required for pathological diagnosis of pancreatic cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

sensitivity of pathological diagnosis using cut-off value

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Endoscopic ultrasound-guided biopsy using a 22-gauge biopsy needle
(If there is no stereomicroscopic visible white core exceeding 11mm, perform additional puncture up to 5 times.)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. providing written informed consent, and age =or >20
2. patients with pancreatic cancer suspected
3. unresectable or borderline resectable

Key exclusion criteria

1. patients with mental disorder
2. patients whose participation in the trial was judged to be inappropriate by the investigator

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Kosuke
Middle name
Last name Okuwaki

Organization

Kitasato University School of Medicine

Division name

Department of Gastroenterology

Zip code

252-0374

Address

1-15-1, Kitasato, Minami-ku, Sagamihara Kanagawa 252-0374, Japan

TEL

042-778-8111

Email

kokuwaki@kitasato-u.ac.jp


Public contact

Name of contact person

1st name Masafumi
Middle name
Last name Watanabe

Organization

Kitasato University School of Medicine

Division name

Department of Gastroenterology

Zip code

252-0374

Address

1-15-1, Kitasato, Minami-ku, Sagamihara Kanagawa 252-0374, Japan

TEL

042-778-8111

Homepage URL


Email

m.wata@kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kitasato University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato University school of medicine, Institutional Review Board

Address

1-15-1, Kitasato, Minami-ku, Sagamihara Kanagawa 252-0374, Japan

Tel

042-778-8111

Email

rinrib@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Kitasto University Hospital(Kanagawa),Isehara Kyodo Hospital(Kanagawa),JCHO Sagamino Hospital(Kanagawa)


Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

70

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2019 Year 12 Month 17 Day

Date of IRB

2020 Year 02 Month 12 Day

Anticipated trial start date

2020 Year 02 Month 15 Day

Last follow-up date

2021 Year 12 Month 21 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 16 Day

Last modified on

2021 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044515


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name